What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?-Reference-Cited by-同舟云学术

What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?

Published:2022-12-09 Issue: Volume: Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Baboudjian Michael^ORCID,Roubaud Guilhem,Fromont Gaëlle,Gauthé Mathieu,Beauval Jean-Baptiste,Barret Eric,Brureau Laurent,Créhange Gilles,Dariane Charles,Fiard Gaëlle,Mathieu Romain,Ruffion Alain,Rouprêt Morgan,Renard-Penna Raphaële,Sargos Paul,Ploussard Guillaume,

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://link.springer.com/content/pdf/10.1007/s00345-022-04239-1.pdf

Reference51 articles.

1. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10

2. Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR (2013) Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol 2:215

3. Minamimoto R, Loening A, Jamali M et al (2015) Prospective comparison of 99mTc-MDP scintigraphy, combined 18F-NaF and 18F-FDG PET/CT, and whole-body MRI in patients with breast and prostate cancer. J Nucl Med 56(12):1862–1868

4. Hövels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63(4):387–395

5. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–2499

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Management and Future Treatment Strategies for Patients with Metastatic Hormone-Sensitive Prostate Cancer;World Journal of Urology;2023-07-31